The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Clinical utility of telomerase in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 2×
“Using a PCR-based telomerase assay called TRAP (Telomeric Repeat Ampli®cation Protocol) (Kim et al., 1994) telomerase activity has been found in approximately 85% of the most common cancers such as breast, prostate, lung, liver, pancreatic, and colon cancers (Kim, 1997; Shay and Bacchetti, 1997),…”
MethodA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 2×
“In other instances, in which the level of telomerase activity is not high but increases with cancer progression (Shay and Bacchetti, 1997), telomerase activity levels in tumor tissues may be prognostic indicators of patient outcome.”
BackgroundTelomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256 · cited 1×
“Regulation of telomerase activity correlates with the expression of two major components: human telomerase RNA (hTR) (Feng et al., 1995) and human telomerase reverse transcriptase (hTERT) (Nakamura et al., 1997).”
BackgroundThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Activation of telomerase in human lymphocytes and hematopoietic progenitor cells
Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Hiyama, E., Piatyszek, M. A., Shay, J. W., Ishioka, S., & Yamakido, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3711 · Cited by 853
Self-citationCorrelating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Self-citation
Cited by
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy
Czauderna, P., Lopez-Terrada, D., Hiyama, E., Häberle, B., Malogolowkin, M. H., & Meyers, R. L. (2014) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000046 · Cited by 306
Self-citationBura, A., Planat-Benard, V., Bourin, P., Silvestre, J.-S., Gross, F., Grolleau, J.-L., Saint-Lebese, B., Peyrafitte, J.-A., Fleury, S., Gadelorge, M., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2013.11.011 · Cited by 297
Blasco, M. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc862 · Cited by 175
Genes and pathways downstream of telomerase in melanoma metastasis
Bagheri, S., Nosrati, M., Li, S., Fong, S., Torabian, S., Rangel, J., Moore, D. H., Federman, S., LaPosa, R. R., Baehner, F. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510085103 · Cited by 129
Evolving views of telomerase and cancer
Blasco, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00085-0 · Cited by 123
Metadata
- Authors
- Hiyama, E., & Hiyama, K.
- Venue
- Oncogene
- Published
- 2002-01-21
- Volume
- 21
- Issue
- 4
- Pages
- 643-649
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2083627770
- Cited by
- 202
- References
- 6
- FWCI
- 13.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical utility of telomerase in cancer. https://app.cochat.ai/papers/10.1038/sj.onc.1205070
- The paper
- Hiyama, E., & Hiyama, K. (2002). Clinical utility of telomerase in cancer. Oncogene. https://doi.org/10.1038/sj.onc.1205070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.